European Journal of Molecular & Clinical Medicine

Abstract

Objective: The aim of study was to ensure supply of safe and efficient blood transfusion to
patient and to prevent Transfusion Transmitted Diseases.
Methods: The present study included data of routine monthly analysis of whole blood and
blood components which was collected from archives of blood bank from the period of 1st
January 2018 to 31st December 2019. Data was collected for the above mentioned period in
which blood was collected from 2520 healthy donors in sterile single, double or triple blood
bags with anticoagulant Citrate Phosphate Dextrose Adenine 1 (CPDA 1) after taking written
consent.
Result: Mean volume was 65.5 mL with range of 50-70 mL. Mean WBC contamination was
1.4×108/unit with a range of 0.15-5.5×108/unit. Mean RBC contamination was
0.077×1012/liter with a range of 0.05- 0.14x1012/liter.
Conclusion: Quality indicators should be well-defined, regularly monitored and properly
documented. Quality Control is an important tool to ensure maximum benefit to patient with
minimum cost and maximum advantage and minimizing requirement of transfusion to patient
and Prevention of risk of Transfusion Transmitted Diseases.